Recent studies and case reports have revealed concerning neurological effects of SARS-CoV-2 infections, including the development of brain calcifications. These calcifications can occur rapidly in rare cases or gradually over time in most cases. Additionally, exposure to the virus has been linked to the development of Fahr’s syndrome, a rare neurological disorder characterized by abnormal calcium deposits in the brain. Symptoms of Fahr’s syndrome can range from motor function deterioration to seizures and neuropsychiatric problems.
The presence of cerebral calcifications in individuals infected with SARS-CoV-2 has been confirmed by several case reports and studies. This highlights the importance of considering Fahr’s syndrome as a possible diagnosis in patients with COVID-19 and neurological symptoms. Symptoms of Fahr’s syndrome can include cognitive impairments, movement-related issues, and motor function deterioration. Some symptoms may resemble those seen in Parkinson’s disease.
A recent case study published in the Archives of Clinical Neuropsychology described a 75-year-old patient who experienced mood disturbances, motor abnormalities, and cognitive difficulties after a COVID-19 infection. Neuroimaging revealed bilateral basal ganglia calcifications and white matter lesions. The patient’s neuropsychological assessment indicated weaknesses in attention, memory, processing speed, mental flexibility, and motor function. The patient was possibly diagnosed with Fahr’s syndrome. This case highlights the need for healthcare professionals to consider various potential causes, including the effects of COVID-19, when evaluating patients with cognitive difficulties.
As more cases of neurological manifestations associated with COVID-19 emerge, healthcare professionals must remain vigilant in diagnosing and treating patients. It is crucial to consider the possibility of Fahr’s syndrome and conduct brain MRIs to check for cerebral calcifications. The understanding of the neurological effects of COVID-19 continues to evolve, emphasizing the need for ongoing research and awareness in the medical community.